Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

phenotyping

- PMLiVE

Novartis’ Entresto launched in UK

Drug was first CHF therapy to show an improvement over ACE inhibitors

- PMLiVE

Biomedical Catalyst funding ‘must continue’, says BIA

UKbiotech body warns against re-appearance of funding 'valley of death'

- PMLiVE

UCB and MRC join forces on novel antibody discovery platform

Will provide UK scientists with access to up-to-date technologies

UK Life Sciences Strategy - one year on

AstraZeneca joins Genomics England consortium

Combines with other pharma firms such as Illumina to utilise genetic data to create new medicines

- PMLiVE

UK CROs to offer drug discovery services to Nordic businesses

Will head to Copenhagen in March for market visit

- PMLiVE

Novartis begins sale talks for Horsham, UK site

Enters negotiations with the University of Brighton

Creating a 21st century life sciences ecosystem

The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation

- PMLiVE

Industry welcomes UK’s £6bn science strategy

It will provide funding for projects including a big data collaboration and an ageing-focused innovation centre

- PMLiVE

MRC Technology and Yabao form Parkinson’s partnership in China

Companies will target specific kinase involved in neurodegeneration

UK flag

UK to review life sciences environment

Intends to speed up access to medicines and medical technologies

- PMLiVE

Brain tumour vaccine is UK’s first ‘Promising Innovative Medicine’

Northwest Biotherapeutics’ DCVax-L gets UK version of ‘breakthrough’ status for use in cancer

- PMLiVE

NICE knocks back Celgene’s Abraxane in pancreatic cancer

Says cancer drug's cost not justified by its limited benefit

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links